Ozempic dosing and dental offices: what TikTok gets wrong

What did @westchasesmilesinstitute actually say?

The creator, appearing to be from a dental practice, answered two questions about what they repeatedly called "osmosis" (clearly meaning Ozempic/semaglutide). They said it is "normally administered once a week," that patients can receive it in the office or take a package home to self-inject, and that a missed dose is "not a problem" because you can "just take it as soon as you remember." That is the full scope of the medical guidance offered here. No dosing amounts, no clinical context, and no mention of the dose escalation schedule that actually defines how this drug works.

Worth noting upfront: a dental practice offering GLP-1 injections is not standard. Dentists operate under specific state scope-of-practice laws, and administering semaglutide injections sits outside traditional dental care in most U.S. jurisdictions. That context matters when evaluating who is giving this advice.

Does the science back this up?

On the core pharmacology, yes. Semaglutide has a half-life of approximately one week, which is exactly why once-weekly subcutaneous dosing works. The FDA-approved prescribing information for Ozempic confirms this schedule. So the "once a week" claim is not wrong.

The missed-dose guidance is trickier. The FDA label for Ozempic does state that if a dose is missed, it can be taken as soon as possible, provided the next scheduled dose is at least five days away. If the gap is less than five days, you skip the missed dose entirely and resume the regular schedule. The creator omitted this five-day rule entirely, which is a clinically meaningful detail. Marso et al. (2016, New England Journal of Medicine), the SUSTAIN-6 trial, and the prescribing label all establish semaglutide's pharmacokinetic profile, which is what makes that five-day window relevant. Ignoring it is not a minor omission.

What did they get wrong (or right)?

They got the weekly dosing frequency right. Credit where it is due. Semaglutide's pharmacokinetics are well-established, and "once a week" is accurate and consistent with all approved labeling.

What they got wrong is the missed-dose instruction. Saying you can "just take it as soon as you remember" without any qualification is incomplete in a way that could cause real harm. If a patient takes a missed dose and their next scheduled dose falls within five days, they would effectively be stacking doses closer together than intended. At higher doses in the escalation schedule, that increases exposure to nausea, vomiting, and in rare cases, more serious gastrointestinal events documented in the SUSTAIN trial series.

They also called the drug "osmosis" throughout, which is just an error. It is a minor point, but a provider offering injections of a medication probably should be able to pronounce it consistently.

What should you actually know?

Semaglutide is a once-weekly injection. That part is correct. But the clinical picture is more involved than this video suggests. Ozempic is FDA-approved for type 2 diabetes management; Wegovy is the approved form for chronic weight management. They contain the same molecule at different dose ceilings. Compounded semaglutide, which some telehealth and medical spa operations dispense, is not FDA-approved and cannot be treated as equivalent to branded products.

On missed doses: the five-day rule matters. Davies et al. (2021, Diabetes Care) noted that semaglutide's long half-life provides some buffer, but that buffer has limits. If you miss a dose and your next one is fewer than five days away, skip the missed one. Taking two doses in close succession without medical guidance is not recommended.

If a dental office is offering you semaglutide injections, ask direct questions about who is prescribing it, what their licensing covers, and how dose escalation is being managed. These are not unreasonable questions. They are necessary ones.

Bottom line

This video is not dangerous in a dramatic way, but it is incomplete in ways that matter. The weekly frequency is correct. The missed-dose advice skips a rule that the FDA label explicitly includes. And a dental-practice TikTok is a genuinely unusual source for GLP-1 guidance. If you are on semaglutide or considering it, the prescribing information and a licensed prescriber who knows your full medical history are the appropriate resources, not a 30-second clip from a dental office account.